Merck said on Tuesday a study showed its injectable version of cancer drug Keytruda was not inferior to the currently ...

Experts view BridgeBio’s acoramidis—which has an FDA action date of Nov. 29—as either similar to or incrementally better than ...

A Las Vegas woman is not only fighting for her life, but also against a pharmaceutical company after her tumors could be ...

We recently compiled a list of the Jim Cramer Talked About These 11 Stocks Recently. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other stocks Jim ...

Pfizer's latest COVID booster targets Omicron JN.1. Learn who should get it and why it’s essential for protection.

From a new market intelligence platform to an AI-powered smart wallet, these technologies are changing the way we think of ...

Following US President-elect Donald Trump's announcement that Robert F Kennedy (RFK) Jr will be appointed as head of the ...

Robert F. Kennedy Jr.'s nonprofit, Children’s Health Defense, is involved in vaccine lawsuits against agencies he could wind ...

An open-label extension study of the phase 3 ATTRibute-CM trial shows that acoramidis produced reductions of 36% and 34% in ...

The Trump presidency and mooted ascension of prominent vaccination opponent Robert F. Kennedy Junior to head the US ...

Air Commodore David Olumuyiwa Babalola, consultant clinical pharmacist in the Nigerian Air Force (NAF), has won three prestigious honours ...

Biotech-stock investing has one tough test for success - and it's about to get easier ...